AVITA Medical, Inc. (RCEL) Net Income (Loss) Attributable to Parent USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
AVITA Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • AVITA Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$18.7 M, a 102% decline year-over-year.
  • AVITA Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$44.8 M, a 69.6% decline year-over-year.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.4 M, a 32.7% decline from 2022.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.7 M, a 0.31% decline from 2021.
  • AVITA Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.6 M, a 36.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$44.8 M -$18.7 M -$9.44 M -102% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$35.4 M -$7.07 M -$1.71 M -32% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$33.7 M -$8.71 M -$3.12 M -55.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$30.5 M -$10.4 M -$4.12 M -65.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$26.4 M -$9.22 M +$243 K +2.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$26.7 M -$5.35 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$5.59 M +$360 K +6.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$6.26 M -$1.54 M -32.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9.46 M -$3.47 M -57.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$22.3 M -$5.95 M +$4.28 M +41.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$26.6 M -$4.72 M +$8.2 M +63.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$34.8 M -$6 M +$9.05 M +60.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$43.8 M -$5.64 M +$4.86 M +46.3% Oct 1, 2020 Dec 31, 2020 10-K 2021-08-26
Q3 2020 -$48.7 M -$10.2 M -$6.66 M -187% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$42 M -$12.9 M -$5.29 M -69.5% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-26
Q1 2020 -$36.7 M -$15 M -$8.87 M -143% Jan 1, 2020 Mar 31, 2020 10-K 2021-08-26
Q4 2019 -$27.9 M -$10.5 M -$4.24 M -67.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-26
Q3 2019 -$23.6 M -$3.57 M +$1.47 M +29.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-26
Q2 2019 -$25.1 M -$7.62 M Apr 1, 2019 Jun 30, 2019 10-K 2020-08-27
Q1 2019 -$6.18 M Jan 1, 2019 Mar 31, 2019 10-K 2020-08-27
Q4 2018 -$6.27 M Oct 1, 2018 Dec 31, 2018 10-K 2020-08-27
Q3 2018 -$5.03 M Jul 1, 2018 Sep 30, 2018 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.